The Foundation
The Parker Foundation aggressively pursues solutions to an array of entrenched problems impacting millions of people, building on the momentum that Sean Parker achieved in a decade of independent philanthropy. We believe philanthropy with a capacity for experimentation is the most effective. We target our resources toward the best people doing the most promising work and then we provide unrestrained support. We believe that’s how problems get solved.
With these approaches in mind, the Parker Foundation was launched in June 2015 through a $600 million gift by Sean and Alexandra Parker. The foundation builds upon the Parkers’ historical philanthropic support and capitalizes on their pioneering work in the fields of technology, media, company building, and public policy. Based in San Francisco, the foundation aggressively pursues large-scale systemic change in four focus areas: Life Sciences, Global Public Health, Civic Engagement and the Arts.
About Sean Parker
Sean Parker is a philanthropist and entrepreneur with a record of launching genre-defining companies and organizations. He was the co-founder of Napster at age 19 and of Plaxo at 21. In 2004 he partnered with Mark Zuckerberg to found Facebook and served as its first president. In 2007 he co-founded Causes on Facebook, which registered 180 million people to donate and take action around social issues. During his tenure as Managing Partner at Founders Fund where he invested in companies such as Airbnb, Stripe, Deepmind, Lyft, Palantir and SpaceX, Mr. Parker became Spotify’s first American investor.
He is currently CEO of Cantina Labs, Executive Chairman of Stability AI, and a Board Member of Weta FX.
Mr. Parker also serves on the Boards of Directors for the following biotech companies: Arsenal Bio; Dispatch Biotherapeutics; 3T Biosciences; Georgiamune; Moonlight Bio; Twain Therapeutics; and Xaira Therapeutics.
He is the Founder and Chairman of the Parker Institute for Cancer Immunotherapy (PICI) which builds on Mr. Parker’s leadership in funding and promoting research into the relationship between the immune system and cancer. In less than a decade, PICI has become a leader in the immunotherapy field for cutting edge research collaboration and clinical development, including funding a landmark human trial using CRISPR technology.
Mr. Parker is President of the Parker Foundation, based in San Francisco, and the Chairman and Founder of the Economic Innovation Group (EIG), based in Washington D.C. He was a key architect behind EIG’s groundbreaking Opportunity Zones program, a community investment tool that connects private capital with low-income communities across America.
He is on the Obama Foundation's Board of Directors and the Museum of Contemporary Art’s Board of Trustees.
Mr. Parker has received honors including the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research CRI; the Pontifical Key Philanthropy Award from the Vatican; the Jefferson Foundation Award for Outstanding Public Service by a Private Citizen; and the Friends of Cancer Research Cancer Leadership Award. UCLA Mattel Children’s Hospital awarded Mr. Parker their highest honor, the Kaleidoscope Philanthropic Leadership Award. The Society for Immunotherapy of Cancer (SITC) presented him with their Public Service Award for his efforts in championing cancer immunotherapy. He was nominated as a Wired Magazine “Icon" alongside Alex Marson for their roles in the research of DNA programming and genome editing in the fight against cancer. Mr. Parker received the Gold Medal of Honorary Patronage from Trinity College, Dublin, and the Kemp Leadership Award for his leadership on Opportunity Zones.
He has been included on influential lists including Forbes' 100 Greatest Business Minds, Vanity Fair’s New Establishment, Billboard’s Power 100, Time Magazine's 50 Most Influential People in Health Care, Politico's Politico 50, and Chronicle of Philanthropy’s Philanthropy 50, among others.
He lives in Los Angeles with his wife Alexandra and their two children.
About Alexandra Parker
As a founding board member of The Parker Foundation, Alexandra Parker is an active philanthropist in the field of life sciences and public health and was instrumental to the formation of the Parker Institute for Cancer Immunotherapy. Alexandra was recognized alongside Sean Parker with the Kaleidoscope Philanthropic Leadership Award from UCLA’s Mattel Children’s Hospital for the Parker Foundation’s work to support groundbreaking collaborative scientific research into cancer and the immune system.
Alexandra also has a deep passion for helping those struggling with opiate addiction and is working to support the recovery process. Beyond Alexandra’s philanthropic work, she is an artist, musician and dedicated mother to two children.